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httpcense.Abstract Background: Sleep disorders are common and the gold standard for diagnosis is through
polysomnography (PSG) with standard ‘scoring criteria. Published clinical and polysomnographic
data reporting sleep disorders among Egyptian patients are lacking.
Aim: To study clinical and polysomnographic characteristics in Egyptian patients with suspected
sleep disorders.
Patients and methods: All patients’ polysomnographic records and sleep questionnaires were
reviewed from November 2006: November 2012 at the Minouﬁya University Hospital Sleep Disor-
ders Unit.
Results: 421 patients were recruited among which 229 were males (54.4%); excessive daytime
sleepiness and obesity were major features (ESS = 16, BMI = 33). Most of the patients were
referred by a chest physician (81%). The most common symptoms were snoring (84.6%), witnessed
apneas (78.6%), insomnia (70.9%) while the least was parasomnia (15.4%). 337 patients were diag-
nosed as having obstructive sleep apnea OSA (80%) of them, 70 (21%) had mild OSA, 75 (22%)
had moderate OSA and 192 (57%) had severe OSA, The most common diseases accompanying
OSA were: systemic hypertension (77%), diabetes (63%), COPD (57%), and coronary heart disease
(49%).
Conclusions: Sleep medicine in Egypt is still lagging behind the developed world, awareness of
sleep disorders among Egyptian physicians should be increased. Diabetes, HTN, IHD and COPD
are the commonest predisposing factors for OSA among Egyptians especially snorers, obese and
overweight patients.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.8818827.
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Sleep occupies one third of people’s lives. Nevertheless, sleep
science and sleep medicine have only recently been established
as scientiﬁc and medical disciplines. Advances in knowledge
and treatment have been accelerating and have resulted in
improvements in the quality of life of the human populaceis. Production and hosting by Elsevier B.V.
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718 M. Yousif, R. El-Helbawy[1]. Although many sleep disorders can be diagnosed clinically,
some require further evaluation in a sleep laboratory. In sus-
pected sleep-related breathing disorders, a full-night polysom-
nogram (PSG) is recommended [2]. Standard PSG scoring
rules using the criteria of Rechtschaffen and Kales [3] have re-
cently been revised and updated by the American Academy of
Sleep Medicine [4]. Obstructive events of the airway during
sleep can either be partial (hypopnea) or complete (apnea).
Sleep apnea or hypopnea is deﬁned by a minimum duration
of ten seconds to be scored. When these episodes are associated
with clinical manifestations such as unrefreshing sleep, noctur-
nal sleep disruption, fatigue, or daytime sleepiness it is termed
as obstructive sleep apnea syndrome (OSAS) [5].
To our knowledge, there are no published data reporting
the results of sleep questionnaires and comprehensive sleep
studies using standard scoring criteria for Egyptian patients.
Accordingly, the aim of the current study was to study clinical
and polysomnographic characteristics in Egyptian patients
with suspected sleep disorders.
Patients and methods
This was a retrospective analysis of PSG and sleep question-
naire data in a large group of patients with suspected sleep dis-
orders who underwent comprehensive diagnostic PSG
evaluation in the Sleep disorders unit of a public tertiary Egyp-
tian hospital. This study was approved by the hospital’s Insti-
tutional Review Board. The studied population was 421
patients recruited from a consecutively encountered patient
population seen over a 6-year period at the Minouﬁya Univer-
sity Hospital Sleep Disorders Unit. This is a one-bedded sleep
laboratory of a tertiary hospital, staffed by a team of pulmo-
nologists who obtained special training in practicing sleep
medicine and consultations can be obtained from various hos-
pital consultants for help in the diagnosis of non-pulmonary
sleep disorders including neurologists, ENT surgeons and psy-
chiatrists. The sleep lab works 3 nights/week as a maximum.
On the day of the study and before electrode application the
patient completes a sleep questionnaire which involves the list
of his symptoms, anthropometric measures (height, weight and
neck circumference), his sleep habits, concurrent diseases (as
DM, HTN, cardiac, pulmonary, . . ..) a list of his medications,
and lastly the Epworth sleepiness scale. PSG was performed
for patients with clinically suspected OSA who experienced
any one of the following sleep-related symptoms: Excessive
daytime sleepiness, snoring, witnessed apneas, choking or
gasping in sleep, sleep maintenance insomnia, or un-refreshing
sleep. For the patient to be familiar with the study, a full
description of the study protocol was done by the well trained
sleep technician. Overnight PSG was performed using Embla
S4000 Medcare, Iceland. The system has Somnologica studio
3.3.2 software, electrodes and cables to record the electroen-
cephalogram (EEG), electrooculogram (EOG), electromyo-
gram (EMG) of the chin and bilateral tibialis anterior
muscles, and electrocardiogram (ECG). Airﬂow was measured
using nasal and oral thermistors, and a nasal pressure trans-
ducer. Respiratory effort was monitored with respiratory
inductive polysomnography belts with thoracic and abdominal
locks. Oximetry was measured using a disposable ﬁnger probe
(oximeter ﬂex sensor 8000 J) placed on the index ﬁnger.
Snoring was recorded using snore microphones (piezo snoringsensor) attached to the neck. Body position was monitored
using body position sensor. All studies were analyzed by
trained PSG technicians and sleep physicians using the criteria
of Rechtschaffen and Kales, and in close concordance with
scoring updates given by the American Academy of Sleep
Medicine. The traditional Rechtschaffen and Kales terminol-
ogy for the 5 sleep stages (i.e. stages 1, 2, 3, 4, and REM sleep,
with stages 1 and 2 collectively referred to as ‘‘light sleep’’,
stages 3 and 4 collectively referred to as ‘‘deep sleep’’) was used
in this study. Apneas were scored when there was a complete
cessation of airﬂow orP90% drop in the peak thermal sensor
excursion for at least 10 s. Hypopneas were scored when there
was a drop in nasal pressure by P30% of baseline lasting at
least for 10 s with a P4% desaturation from pre-event base-
line, or when there was a drop in nasal pressure signal excur-
sion by P50% of baseline lasting at least for 10 s with a
P3% desaturation from pre-event baseline. The apnea–hypo-
pnea index (AHI) which is number of apnea–hypopnea events
per hour was determined after the exclusion of periods with
movements, which were considered to be wake periods. An ap-
nea without chest or abdominal movements was classiﬁed as
CSA and apnea with chest and abdominal movements was
classiﬁed as OSA. Hypopneas were considered to be obstruc-
tive when there was evidence of upper airway obstruction, such
as snoring, paradoxical respiratory band movement or inspira-
tory ﬂow limitation through the nasal cannula; central hypo-
pnea, in contrast, was associated with in-phase respiratory
movements and no evidence of inspiratory ﬂow limitation.
SDB was considered to be central if greater than 50% of
apnea/hypopnea events were central and obstructive if greater
than 50% were obstructive [4].
Statistical analysis
The data were analyzed collectively and presented as median
and range for all patients and those with OSA. Some data as
symptoms, referral, co-morbidities and diagnosis were pre-
sented as percent of total then data were grouped according
to severity of sleep-disordered breathing and BMI. Pearson
correlation coefﬁcient was used to test the association between
AHI and other parameters with statistical signiﬁcance taken as
P< 0.05. The data collected were analyzed by SPSS (statisti-
cal package for the social science software) statistical package
version 14.
Results
The most frequent symptoms were snoring 84.6%, apnea
78.6%, insomnia 70.9%, excessive daytime sleepiness 68.4%
and the least was parasomnia 15% (Fig. 1).
Most of the patients were referred by chest physicians
(81%), 9% by ENT physicians, 6% by neuropsychiatry physi-
cians and 4% by other specialties (cardiology, internal medi-
cine, family physicians) (Fig. 2).
As regards the ﬁnal diagnosis; the commonest was OSA
(OSA alone 40.4%, OSA+ Insomnia 23.7%, OSA + PLM
15.9%), followed by insomnia 12%, and the least frequent
diagnosis was PLM disorder 0.7% (Fig. 3).
The patient characteristics and polysomnographic data of
all the studied cases are shown in Table 1. Out of the studied
421 patients, 229 (54.4%) were males, excessive daytime
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Figure 3 Diagnosis frequency of all the studied patients.
Table 1 Patient characteristics and polysomnographic data of
all studied cases.
Patients’ characteristics Number Percentage
Sex: male (n, %) 229 54.4
Female (n, %) 192 45.6
Median Range
Age (Median) (range) 54 14–88
ESS (Median) (range) 16 0–24
BMI (Median) (range) 33 16–86
Polysomnography data
Sleep eﬃciency% 59 3–99
Sleep latency 14 0–477
REM latency 99 0–544
AHI 27 0–150
Desaturation index 27 0–157
Light sleep% 35 0.5–100
Deep sleep% 53 0–99
REM% 6 0–55
Arousal index 34 0–174
Baseline O2 94 8–99
Average O2 91 8–99
Lowest O2 80 50–88
Flow limitation index 15 0–100
PLM 6 0–50
ESS: Epworth sleepiness scale, BMI: body mass index, REM rapid
eye movement, AHI: apnea–hypopnea index, PLM: periodic limb
movement.
An Egyptian sleep lab experience 719sleepiness and obesity were major features (ESS = 16,
BMI = 33). Regarding the polysomnographic data, the gen-
eral features were reduced sleep efﬁciency, prolonged sleep la-
tency, a high apnea–hypopnea, desaturation and arousal
indices.
Table 2 shows signiﬁcant positive correlations between AHI
and each of BMI, ESS, DI, arousal index and PLM. However,
a signiﬁcant negative correlation was found between AHI and
sleep efﬁciency.
Table 3 shows the patient characteristics and polysomno-
graphic data of patients with OSA. Out of the 337 patients
with OSA, 181 (53.7%) were males, excessive daytime sleepi-
ness and obesity were major features (ESS = 16, BMI = 36).
Regarding the polysomnographic data, the general features
were reduced sleep efﬁciency, prolonged sleep latency, a high
apnea–hypopnea, desaturation and arousal indices.
Fig. 4 shows the commonest co-morbidities in patients with
OSA. The highest frequencies are systemic hypertension
(HTN) (77%), diabetes (63%), COPD (57%) and coronary
heart disease (49%). While, all other diagnoses such as bron-
chial asthma, interstitial pulmonary ﬁbrosis, hepatitis C virus
infection, and hypothyroidism represent 38%.Regarding the categorization of OSA patients according to
AHI; the patients with OSA were grouped into mild OSA
(21%), moderate OSA (22%) and severe OSA (57%) (Fig. 5).
Discussion
The total number of patients recruited in this study along
6 years was 421 patients. This may be a small number com-
pared to the period of recruitment. This may be due to the
reduced awareness of sleep disorders, the complexity, the cost
of a full polysomnographic recording, so the referral rate was
low especially at the beginning and limited resources of our
sleep unit (one-bedded sleep lab, works 3 nights/week as a
maximum) but still it is a study with a relatively large sample
size.
The prevalence of OSA is estimated to be 4–10% in middle-
aged general populations of predominantly Caucasian origin
Table 2 Pearson correlation between apnea–hypopnea index and some other variables.
AHI BMI ESS SE DI Arousal index PLM
r p-Value r p-Value r p-Value r p-Value r p-Value r p-Value
0.65 0.001 0.58 <0.001 0.31 0.011 0.92 <0.001 0.81 <0.001 0.5 <0.001
BMI body mass index, ESS: Epworth sleepiness scale, SE: sleep efﬁciency, DI: desaturation index, PLM; periodic limb movement.
Table 3 Patient characteristics and polysomnographic data of
patients with OSA.
Patients’ characteristics Number % of OSA
Sex: male (n, %) 181 53.7
Female 156 46.3
Median Range
Age (Median) (range) 55 14–85
ESS (Median) (range) 16 0–24
BMI (Median) (range) 36 16–86
Polysomnography data
Sleep eﬃciency% 59 3–99
Sleep latency 13 0–477
REM latency 90 0–544
AHI 36 5–150
Desaturation index 38 1–157
Light sleep% 35 1–100
Deep sleep% 53 0–99
REM% 7 0–55
Arousal index 41 0–174
Baseline O2 94 8–99
Average O2 90 8–99
Lowest O2 78 50–88
Flow limitation index 7 0–100
PLM 3 0–50
OSA: obstructive sleep apnea, ESS: Epworth sleepiness scale, BMI:
body mass index, REM rapid eye movement, AHI: apnea–hypo-
pnea index, PLM: periodic limb movement.
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720 M. Yousif, R. El-Helbawy[6]. Although our study included a selected pool of patients
who were referred for snoring and the possibility of OSA
and we have not determined the prevalence of OSA in Egypt,
we have shown that the condition is perhaps not uncommon in
Egyptian snorers.
The most frequent symptoms were snoring 84.6%, apnea
78.6%, insomnia 70.9%, excessive daytime sleepiness 68.4%
and the least was parasomnia 15% (Fig. 1). This matches the
results of Abisheganaden et al. [7] which showed that all their
patients (n= 125) had a history of snoring (100%) while thosewith OSA (n= 72), 78% also had excessive daytime sleepi-
ness. This can be explained by the fact that most of the patients
were referred by chest and ENT physicians and by the criteria
of referral which were snoring and sleep apneas. About insom-
nia, it is usually an accompanying symptom of most sleep
disorders.
Most of the patients were referred by chest physicians
(81%), 9% by ENT physicians, 6% by neuro-psychiatrists
and 4% by other specialties (cardiology, internal medicine,
family physicians) (Fig. 2). The commonest diagnosis was
OSA (OSA alone 40.4%, OSA+ Insomnia 23.7%,
OSA+ PLM 15.9%), followed by insomnia 12%, the least
frequent diagnosis was PLM disorder 0.7% (Fig. 3). As the
main symptoms that alert attention of sleep disordered breath-
ing are snoring and sleep apneas, the suspicion of sleep apnea
was the criterion for referral to the lab. This matches the re-
sults got by BaHammam [8]. In his study, referrals by otolar-
yngologists represented 8% of OSA patients, compared to
17.4% in the United States [9]. BaHammam explained this
ﬁnding by (1) reduced awareness of some of the otolaryngolo-
gists of the importance of PSG to conﬁrm the diagnosis and
severity of suspected OSA to tailor treatment according to
the patient’s needs; (2) some may feel that their clinical assess-
ment is enough to assess the severity of the illness, (3) or there
is a communication gap between otolaryngologists and sleep
specialists.
The median age of all the studies patients was 54 years
(Table 1) and for those with OSA it was 55 years (Table 3).
This revealed an increased prevalence of sleep disordered
breathing (SDB) among elderly. Ip et al. [10] reported that,
the prevalence of SDB increased nearly 12 folds in the 50–
60 year old group, compared to 30–39 year old group. Martin
et al. [11] study showed that SDB is common among elderly
and a potential risk factor for mortality during sleep. The
physiological changes that occur with advancing age in the
form of reduction in upper airway size, with increased its col-
lapsibility, inadequate compensatory action of upper airway
dilator muscles, decreased vital capacity and altered ventila-
tory control contribute to occurrence of SDB in the elderly.
An Egyptian sleep lab experience 721Excessive daytime sleepiness and obesity were major fea-
tures for all the patients [(ESS = 16, BMI = 33) Table 1]
and for those with OSA [(ESS = 16, BMI = 36) Table 3], with
signiﬁcant positive correlations between AHI and each of ESS
and BMI (Table 2).
Marry [12] and Uribe et al. [13] evaluated the validity of
ESS in diagnosing SDB, and found that there was a positive
signiﬁcant correlation between ESS and AHI. They
concluded that if ESS was more than 10, SDB should be sus-
pected. They also advised to assess ESS in SDB to rule out or
prove OSA and hence manage it early in the course of the
disease.
The BMI has been one of the most typical parameters in
evaluating the relationship between OSA and obesity. The risk
of OSA also increases with increasing body weight; a 10%
weight gain increases the risk of developing OSA by six-times
[14,15]. Our results match those got by Lim et al. [16] who
studied the PSG data of Singaporean patients evaluated for
OSA in 1-year from a local tertiary sleep disorders unit. They
demonstrated a fair degree of correlation between AHI and
BMI among their patients. Moreover, Sin et al. [17] demon-
strated that the most important risk factor in men for OSA
was increased BMI; this can be related to an increased fat
deposition around the neck which may contribute to pharyn-
geal narrowing and collapsibility.
Regarding the polysomnographic data, the general features
of all patients (Table 1) and of those with OSA (Table 3) were
reduced sleep efﬁciency, prolonged sleep latency, a high ap-
nea–hypopnea, desaturation and arousal indices with a signif-
icant negative correlation between AHI and sleep efﬁciency
(Table 2). This can be explained by the fact that, SDB dis-
rupted sleep continuity (frequent arousals) due to recurrent ap-
nea, leg movement, or oxygen desaturation during sleep are a
potential stimulus for arousal and poor sleep efﬁciency [18].
Fig. 4 showed the commonest co-morbidities in patients
with OSA were systemic hypertension (HTN) (77%), diabetes
(63%), COPD (57%) and coronary heart disease (49%). How-
ever, all other diagnoses such as bronchial asthma, interstitial
pulmonary ﬁbrosis, hepatitis C virus infection, and hypothy-
roidism represent 38%.
Ip mary et al. [19] who studied the polysomnographic and
clinical characteristics of their local patients found that the
common associated medical conditions were hypertension
(34%), diabetes mellitus (10%), ischemic heart disease (9%),
hyperlipidemia (6%) while Jonczak et al. [20] who studied
2052 patients referred to their sleep lab along ten years because
of OSA suspicion found that the most common diseases
accompanying OSA were: systemic hypertension (46%), coro-
nary heart disease (29%), diabetes (12%), and COPD (9%).
This is can be due to the fact that, OSA is an independent risk
factor for hypertension and other cardiovascular complica-
tions and, the more severe the OSA, the more common and se-
vere the hypertension. Moreover, Obstructive sleep apnea also
may impair glucose tolerance. Patients with OSA have higher
levels of fasting blood glucose, insulin, and glycosylated hemo-
globin, independent of body weight [21,22].
In this study, 21% of the patients had mild OSA, 22% had
moderate OSA while 57% had severe OSA (Fig. 5). In Jonczak
et al. [20] study 1194 subjects were diagnosed as having OSA
(AHI > 10), 36% had mild OSA (AHI 11–25), 20% had mod-
erate OSA (AHI 26–40), and 44% had severe OSA
(AHI > 40). Lim et al. [16] found that 419 patients of the stud-ied population had OSA (AHI 6 5) Of those, 31% had mild
OSA (AHI 5–15), 26% had moderate OSA (AHI 15–30),
and 43% had severe OSA (AHI > 30), The explanation of this
high percent of patients with severe OSA may be the delay in
seeking medical advice for the symptom such as snoring which
is considered by most of the patients to be a quite normal per-
sonal ﬁnding and therefore they delay seeking medical atten-
tion until loud disruptive snoring and excessive daytime
sleepiness shown as outstanding symptoms.
This retrospective study was performed based on the data
from a real clinical setting with a relatively large sample size.
Therefore, the clinical characteristics and polysomnographic
ﬁndings of our Egyptian patients could have a number of clin-
ical implications. However, the patients were referred to the
clinic for evaluation of possible sleep apnea. Thus, the results
may have been inﬂuenced by referral bias and survivorship
effects.
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